
-

Trial Underway for Kidney Disease Microbiome Therapy
A clinical trial enrolled its first participant testing an engineered bacterial collection as a treatment for enteric hyperoxaluria, a kidney disorder with no approved cure.
-

Venture Investor to Back Semiconductor Start-Ups
A technology investment company is partnering with a Silicon Valley incubator program to support start-up businesses developing new types of semiconductors.
-

FDA Clears AI Heart Failure Detection System
The Food and Drug Administration authorized for marketing an algorithm-driven medical device for diagnosing a common, but difficult to detect, type of heart failure.
-

Trial Begins Testing Digital Therapy for Anxiety with Lung Disease
A clinical trial is underway testing a mobile app designed to help people with a serious lung disorder manage anxiety that often accompanies the disease.
-

Infographic – Higher HIV Burden for Women, Girls in Africa
The data show falling numbers of young men and women in sub-Saharan Africa with new HIV infections since 2010, but the percentage of infected women and girls also rising over that time.
-

Trial Shows Fast-Absorbing Opioid Overdose Nasal Swab
Results of a clinical trial show a nasal swab dispensing an opioid antidote transfers more of the antidote into the blood stream than syringe injections or nasal sprays.
-

Virtual Pathology Image Company Opens, Raises $15.2M
A developer of virtual tissue staining systems aided by algorithms for medical images began public operations today, raising $15.2 million in venture funds.
-

Sustained-Released Eye Treatment Company Raises $11.9M
A company creating extended-release delivery techniques for eye therapies is raising $11.9 million in its first venture funding round.
-
Give Your Business The Energy Boost it Needs
Making sure you are focused on improving and enhancing your company, and taking the best steps to be successful is super important.
-

Trial Shows Insulin Capsules Reduce Blood Glucose Levels
Results of a clinical trial reveal an optimal dose for an insulin capsule that in 12 weeks reduces blood glucose levels in patients with type 2 diabetes.